Stock Analysis of RVL Pharmaceuticals PLC (RVLP) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code RVLP
Close 0.0118
Change -0.0164 / 58.16 %
Volume 9317.06 K
Vol Change -47897.13 K / 83.72 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthStrong Bearish
Growth Index Low Growth Stock
Value Index Low Value Stock
Profitability Index Poor Profitability Stock
Stability Index Poor Stability Stock


Fundamental View of RVL Pharmaceuticals PLC


Highs/Lows of RVL Pharmaceuticals PLC
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week0.0282 58.16 % 1.54 % 0.0120.004527-Oct-2327-Oct-23
Two Week0.073 83.84 % 3.42 % 0.07850.004518-Oct-2327-Oct-23
One Month0.0803 85.31 % 5.60 % 0.19330.004510-Oct-2327-Oct-23
Three Month0.4086 97.11 % 5.95 % 0.50.004509-Aug-2327-Oct-23
Six Months0.8403 98.60 % 17.48 % 0.970.004528-Apr-2327-Oct-23
One year1.83 99.36 % 27.52 % 1.910.004531-Oct-2227-Oct-23
Two year1.82 99.35 % 29.70 % 2.990.004514-Sep-2227-Oct-23
Five year8.5 99.86 % 85.46 % 1.910.004531-Oct-2227-Oct-23


Technical View of RVL Pharmaceuticals PLC






Charts of RVL Pharmaceuticals PLC


Returns of RVL Pharmaceuticals PLC with Peers
Period / StockRVLPATNFNBSEATNX
1 Week-58.16%-18.13%-6.67%-26.14%
1 Mth-85.31%-17.28%-5.78%-26.14%
3 Mth-97.11%-59.49%-44.41%-87.80%
6mth-98.60%-76.96%-43.95%-96.01%
1 Year-99.36%-91.50%-90.05%-98.46%
2 Year-99.35%-99.67%-98.07%-99.84%
5 Years-99.86%-99.96%-99.26%-99.96%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of RVL Pharmaceuticals PLC with Peers
Ratio / StockRVLPATNFNBSEATNX
PE-0.0129-0.0454-0.0233-0.0004
P/B0.02400.2920.02090.0070
ROA-72.04-192.23-56.60-44.63
ROE-185.93-643.32-89.59-433.13
Debt To Equity1.12-8.100.0285-6.04
Revenue49721.00 K
184.10 %
0
%
0
%
102821 K
14.44 %
Net Income-51692.00 K
20.38 %
-40450.29 K
4.45 %
-33776.45 K
32.93 %
-103427.00 K
48.23 %


Technicals of RVL Pharmaceuticals PLC with Peers
Technical / StockRVLPATNFNBSEATNX-
ADX23.6815.9823.0215.53
CMF-0.375-0.103-0.100-0.091
MFI55.2748.6913.699.16
RSI31.4035.5030.8430.14
MACD Abv SignalFalseTrueTrueFalse
Price Above 50 MAFalseFalseFalseFalse-
Price Above 200 MAFalseFalseFalseFalse-


About : RVL Pharmaceuticals PLC


Address : 400 Crossing Boulevard, Bridgewater, NJ, United States, 08807
Tel : 908 809 1300
URL : https://www.rvlpharma.com
Code : RVLP, ISIN : IE00BF2HDL56, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 18_Oct_2018
Employee Count : 125

RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. It is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.


Note : All Data Generated at the End of Trading Hours (EOD Data)